{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T08:11:28Z","timestamp":1793261488383,"version":"4.5.0"},"reference-count":94,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","surveyophthalmol.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Survey of Ophthalmology"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.survophthal.2024.12.004","type":"journal-article","created":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T02:51:56Z","timestamp":1734490316000},"page":"451-466","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Inflammatory choroidal neovascularization: An evidence-based update"],"prefix":"10.1016","volume":"70","author":[{"given":"Andrea","family":"Servillo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierluigi","family":"Scandale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Oldoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pinar Guran","family":"Begar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Bandello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Miserocchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Vittoria","family":"Cicinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.survophthal.2024.12.004_bib1","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1097\/IAE.0b013e31815e9834","article-title":"Intravitreal bevacizumab (avastin) injection as primary treatment of inflammatory choroidal neovascularization","volume":"27","author":"Ad\u00e1n","year":"2007","journal-title":"Retina"},{"issue":"1","key":"10.1016\/j.survophthal.2024.12.004_bib2","doi-asserted-by":"crossref","DOI":"10.1186\/s12348-018-0155-6","article-title":"An update on inflammatory choroidal neovascularization: epidemiology, multimodal imaging, and management","volume":"8","author":"Agarwal","year":"2018","journal-title":"J Ophthalmic Inflamm Infect"},{"issue":"8","key":"10.1016\/j.survophthal.2024.12.004_bib3","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1097\/IAE.0000000000002176","article-title":"Detection of type 1 choroidal neovascular membranes using optical coherence tomography angiography in tubercular posterior uveitis","volume":"39","author":"Aggarwal","year":"2019","journal-title":"Retina"},{"issue":"4","key":"10.1016\/j.survophthal.2024.12.004_bib4","doi-asserted-by":"crossref","first-page":"148","DOI":"10.4103\/0301-4738.112159","article-title":"Indocyanine green angiography in posterior uveitis","volume":"61","author":"Agrawal","year":"2013","journal-title":"Indian J Ophthalmol"},{"issue":"6","key":"10.1016\/j.survophthal.2024.12.004_bib5","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1080\/17434440.2016.1186540","article-title":"Optical coherence tomography angiography: a non-invasive tool to image end-arterial system","volume":"13","author":"Agrawal","year":"2016","journal-title":"Expert Rev Med Devices"},{"key":"10.1016\/j.survophthal.2024.12.004_bib6","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ajo.2024.01.006","article-title":"Immunomodulatory treatment versus systemic steroids in inflammatory choroidal neovascularization secondary to idiopathic multifocal choroiditis","volume":"262","author":"Airaldi","year":"2024","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.survophthal.2024.12.004_bib7","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1159\/000310695","article-title":"Evaluation of choroidal neovascularization in age-related macular degeneration with fluorescein and indocyanine green videoangiography","volume":"210","author":"Atmaca","year":"1996","journal-title":"Ophthalmologica"},{"issue":"4","key":"10.1016\/j.survophthal.2024.12.004_bib8","doi-asserted-by":"crossref","first-page":"554","DOI":"10.3109\/09273948.2016.1160128","article-title":"Diagnostic challenges in inflammatory choroidal neovascular membranes","volume":"25","author":"Bansal","year":"2017","journal-title":"Ocul Immunol Inflamm"},{"issue":"3","key":"10.1016\/j.survophthal.2024.12.004_bib9","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s10792-017-0536-0","article-title":"Intravitreal anti-vegf treatment for choroidal neovascularization secondary to punctate inner choroidopathy","volume":"38","author":"Barth","year":"2018","journal-title":"Int Ophthalmol"},{"issue":"3","key":"10.1016\/j.survophthal.2024.12.004_bib10","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.ajo.2013.04.040","article-title":"Risk of choroidal neovascularization among the uveitides","volume":"156","author":"Baxter","year":"2013","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.survophthal.2024.12.004_bib11","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s10792-008-9218-2","article-title":"Intravitreal bevacizumab (avastin) as primary and rescue treatment for choroidal neovascularization secondary to ocular toxoplasmosis","volume":"28","author":"Ben Yahia","year":"2008","journal-title":"Int Ophthalmol"},{"issue":"4","key":"10.1016\/j.survophthal.2024.12.004_bib12","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1080\/09273948.2022.2046793","article-title":"Review for diagnostics of the year: Inflammatory choroidal neovascularization \u2013 imaging update","volume":"31","author":"Bou Ghanem","year":"2023","journal-title":"Ocul Immunol Inflamm"},{"issue":"7","key":"10.1016\/j.survophthal.2024.12.004_bib13","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1001\/archopht.126.7.941","article-title":"Bevacizumab treatment for subfoveal choroidal neovascularization from causes other than age-related macular degeneration","volume":"126","author":"Chang","year":"2008","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2024.12.004_bib14","doi-asserted-by":"crossref","DOI":"10.1186\/s12886-021-02197-7","article-title":"RPE disruption and hyper-transmission are early signs of secondary CNV with punctate inner choroidopathy in structure-OCT","volume":"21","author":"Chen","year":"2021","journal-title":"BMC Ophthalmol"},{"issue":"3","key":"10.1016\/j.survophthal.2024.12.004_bib15","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/acel.12447","article-title":"Retinal pigment epithelial cell multinucleation in the aging eye - a mechanism to repair damage and maintain homoeostasis","volume":"15","author":"Chen","year":"2016","journal-title":"Aging Cell"},{"key":"10.1016\/j.survophthal.2024.12.004_bib16","doi-asserted-by":"crossref","DOI":"10.1097\/IAE.0000000000004191","article-title":"APMPPE and placoid variant diseases masquerading as age-related macular degeneration in the elderly: a case series","author":"Cheng","year":"2024","journal-title":"Retina"},{"issue":"5","key":"10.1016\/j.survophthal.2024.12.004_bib17","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/00006982-200210000-00004","article-title":"Long-term follow-up of patients with serpiginous choroiditis","volume":"22","author":"Christmas","year":"2002","journal-title":"Retina"},{"issue":"11","key":"10.1016\/j.survophthal.2024.12.004_bib18","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1097\/IAE.0000000000003602","article-title":"Punctate inner choroidopathy\u2013like reactions in unrelated retinal diseases","volume":"42","author":"Cicinelli","year":"2022","journal-title":"Retina"},{"key":"10.1016\/j.survophthal.2024.12.004_bib19","doi-asserted-by":"crossref","DOI":"10.1097\/IAE.0000000000004150","article-title":"The prognostic significance of acute Henle fiber layer hyperreflectivity in placoid diseases","author":"Cicinelli","year":"2024","journal-title":"Retina"},{"key":"10.1016\/j.survophthal.2024.12.004_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2023.101207","article-title":"Latest advances in white spot syndromes: new findings and interpretations","volume":"97","author":"Cicinelli","year":"2023","journal-title":"Prog Retin Eye Res"},{"issue":"8","key":"10.1016\/j.survophthal.2024.12.004_bib21","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/S0161-6420(96)30515-0","article-title":"Etiology of choroidal neovascularization in young patients","volume":"103","author":"Cohen","year":"1996","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.survophthal.2024.12.004_bib22","doi-asserted-by":"crossref","first-page":"440","DOI":"10.5301\/EJO.2010.6117","article-title":"Visual and optical coherence tomography outcomes of intravitreal bevacizumab and ranibizumab in inflammatory choroidal neovascularization secondary to punctate inner choroidopathy","volume":"21","author":"Cornish","year":"2011","journal-title":"Eur J Ophthalmol"},{"issue":"8","key":"10.1016\/j.survophthal.2024.12.004_bib23","doi-asserted-by":"crossref","first-page":"4372","DOI":"10.4049\/jimmunol.165.8.4372","article-title":"CXCR4 receptor expression on human retinal pigment epithelial cells from the blood-retina barrier leads to chemokine secretion and migration in response to stromal cell-derived factor 1\u03b1","volume":"165","author":"Crane","year":"2000","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.survophthal.2024.12.004_bib24","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1080\/09273948.2019.1704153","article-title":"Inflammatory choroidal neovascularization","volume":"28","author":"Cunningham","year":"2020","journal-title":"Ocul Immunol Inflamm"},{"issue":"8","key":"10.1016\/j.survophthal.2024.12.004_bib25","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/aos.14473","article-title":"The efficacy of corticosteroid-sparing immunomodulatory therapy in treating patients with central multifocal choroiditis","volume":"98","author":"De Groot","year":"2020","journal-title":"Acta Ophthalmol"},{"issue":"11","key":"10.1016\/j.survophthal.2024.12.004_bib26","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1001\/archopht.116.11.1456","article-title":"Immunosuppressive treatment of choroidal neovascularization associated with endogenous posterior uveitis","volume":"116","author":"Dees","year":"1998","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2024.12.004_bib27","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4103\/0301-4738.58467","article-title":"Inflammatory choroidal neovascular membrane in posterior uveitis-pathogenesis and treatment","volume":"58","author":"Dhingra","year":"2010","journal-title":"Indian J Ophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2024.12.004_bib28","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1080\/09273940802650406","article-title":"Intravitreal bevacizumab for uveitic choroidal neovascularization","volume":"17","author":"Doctor","year":"2009","journal-title":"Ocul Immunol Inflamm"},{"issue":"1","key":"10.1016\/j.survophthal.2024.12.004_bib29","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/IAE.0b013e318187aff9","article-title":"Bevacizumab (avastin) and ranibizumab (lucentis) for choroidal neovascularization in multifocal choroiditis","volume":"29","author":"Fine","year":"2009","journal-title":"Retina"},{"key":"10.1016\/j.survophthal.2024.12.004_bib30","article-title":"Choroidal ischemia drives macular neovascularization in persistent placoid maculopathy","volume":"26","author":"Fogel Levin","year":"2022","journal-title":"Am J Ophthalmol Case Rep"},{"issue":"3","key":"10.1016\/j.survophthal.2024.12.004_bib31","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1080\/09273948.2017.1375119","article-title":"Analysis of the clinical profile and management of inflammatory choriodal neovascular membranes in uveitic eyes: a study from a tertiary referral center","volume":"27","author":"Ganesh","year":"2019","journal-title":"Ocul Immunol Inflamm"},{"issue":"6","key":"10.1016\/j.survophthal.2024.12.004_bib32","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1590\/S0004-27492008000600026","article-title":"Intermediate uveitis complicated by choroidal granuloma following subretinal neovascular membrane: Case reports","volume":"71","author":"Garcia","year":"2008","journal-title":"Arq Bras De Oftalmol"},{"issue":"8","key":"10.1016\/j.survophthal.2024.12.004_bib33","doi-asserted-by":"crossref","first-page":"5579","DOI":"10.1167\/iovs.10-6617","article-title":"Spectral-domain optical coherence tomography as an indicator of fluorescein angiography leakage from choroidal neovascularization","volume":"52","author":"Giani","year":"2011","journal-title":"Invest Opthalmol. Vis Sci"},{"issue":"2","key":"10.1016\/j.survophthal.2024.12.004_bib34","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1136\/bjo.2009.177279","article-title":"Vascular endothelial growth factor inhibition in uveitis: a systematic review","volume":"95","author":"Gulati","year":"2011","journal-title":"Br J Ophthalmol"},{"issue":"8","key":"10.1016\/j.survophthal.2024.12.004_bib35","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1007\/s00417-014-2634-2","article-title":"Aflibercept for inflammatory choroidal neovascularization with persistent fluid on intravitreal ranibizumab therapy","volume":"252","author":"Hern\u00e1ndez-Mart\u00ednez","year":"2014","journal-title":"Graefe'S Arch Clin Exp Ophthalmol"},{"issue":"5","key":"10.1016\/j.survophthal.2024.12.004_bib36","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1097\/IAE.0b013e31827e25b8","article-title":"The \u201cpitchfork sign\u201d a distinctive optical coherence tomography finding in inflammatory choroidal neovascularization","volume":"33","author":"Hoang","year":"2013","journal-title":"Retina"},{"issue":"1","key":"10.1016\/j.survophthal.2024.12.004_bib37","doi-asserted-by":"crossref","first-page":"114","DOI":"10.5301\/ejo.5000192","article-title":"Effects of intravitreal bevacizumab on inflammatory choroidal neovascular membrane","volume":"23","author":"Iannetti","year":"2013","journal-title":"Eur J Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2024.12.004_bib38","doi-asserted-by":"crossref","DOI":"10.1186\/s40942-018-0134-y","article-title":"Clinical course of acute zonal occult outer retinopathy complicated by choroidal neovascularization","volume":"4","author":"Introini","year":"2018","journal-title":"Int J Retin Vitr"},{"issue":"3","key":"10.1016\/j.survophthal.2024.12.004_bib39","doi-asserted-by":"crossref","DOI":"10.1097\/IAE.0000000000001978","article-title":"Ocular neovascularization in endogenous candida endophthalmitis: Using multimodal imaging to understand different pathogenic pathways","volume":"38","author":"Invernizzi","year":"2018","journal-title":"Retina"},{"issue":"8","key":"10.1016\/j.survophthal.2024.12.004_bib40","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1136\/bjophthalmol-2019-315257","article-title":"Twenty-four-month outcomes of inflammatory choroidal neovascularisation treated with intravitreal anti-vascular endothelial growth factors: A comparison between two treatment regimens","volume":"104","author":"Invernizzi","year":"2020","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2024.12.004_bib41","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1755-3768.2010.02046.x","article-title":"Intravitreal bevacizumab as first local treatment for uveitis-related choroidal neovascularization: Long-term results","volume":"89","author":"Juli\u00e1n","year":"2011","journal-title":"Acta Ophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2024.12.004_bib42","first-page":"118","article-title":"Inflammatory choroidal neovascular membranes in patients with noninfectious uveitis: The place of intravitreal anti-vegf therapy","volume":"9","author":"Karti","year":"2020","journal-title":"Med Hypothesis Discov Innov Ophthalmol"},{"issue":"19","key":"10.1016\/j.survophthal.2024.12.004_bib43","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1001\/jama.2017.5103","article-title":"Association between long-lasting intravitreous fluocinolone acetonide implant vs systemic anti-inflammatory therapy and visual acuity at 7 years among patients with intermediate, posterior, or panuveitis","volume":"317","author":"Kempen","year":"2017","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.survophthal.2024.12.004_bib44","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.oret.2021.12.015","article-title":"Choroidal neovascularization in a patient with primary vitreoretinal lymphoma","volume":"6","author":"Konstantinou","year":"2022","journal-title":"Ophthalmol Retin"},{"key":"10.1016\/j.survophthal.2024.12.004_bib45","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.2147\/OPTH.S132923","article-title":"Intravitreal aflibercept for choroidal neovascularization associated with chorioretinitis: a pilot study","volume":"11","author":"Korol","year":"2017","journal-title":"Clin Ophthalmol"},{"issue":"11","key":"10.1016\/j.survophthal.2024.12.004_bib46","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1136\/bjo.2009.159913","article-title":"Fluorescein angiography and optical coherence tomography concordance for choroidal neovascularisation in multifocal choroidtis","volume":"94","author":"Kotsolis","year":"2010","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"10.1016\/j.survophthal.2024.12.004_bib47","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1097\/IAE.0b013e3181c96a00","article-title":"Bevacizumab for choroidal neovascularization related to inflammatory diseases","volume":"30","author":"Kramer","year":"2010","journal-title":"Retina"},{"issue":"6","key":"10.1016\/j.survophthal.2024.12.004_bib48","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1177\/24741264231201778","article-title":"Use of adjunctive corticosteroid with antivascular endothelial growth factor agents in the treatment of choroidal neovascular membrane associated with presumed ocular histoplasmosis","volume":"7","author":"Labriola","year":"2023","journal-title":"J Vitreoretina Dis"},{"issue":"8","key":"10.1016\/j.survophthal.2024.12.004_bib49","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1097\/IAE.0000000000001744","article-title":"Efficacy and safety of ranibizumab for the treatment of choroidal neovascularization due to uncommon cause: twelve-month results of the minerva study","volume":"38","author":"Lai","year":"2018","journal-title":"Retina"},{"issue":"1","key":"10.1016\/j.survophthal.2024.12.004_bib50","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/ICB.0b013e31825d8152","article-title":"The use of vascular endothelial growth factor inhibitor for choroidal neovascularization complicating posterior uveitis in eyes with fluocinolone acetonide implants","volume":"7","author":"Lee","year":"2013","journal-title":"Retin Cases Brief Rep"},{"issue":"4","key":"10.1016\/j.survophthal.2024.12.004_bib51","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1083\/jcb.200409115","article-title":"Processing of vegf-a by matrix metalloproteinases regulates bioavailability and vascular patterning in tumors","volume":"169","author":"Lee","year":"2005","journal-title":"J Cell Biol"},{"issue":"1","key":"10.1016\/j.survophthal.2024.12.004_bib52","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1080\/09273948.2018.1489060","article-title":"Punctate inner choroidopathy and choroidal neovascularization in korean patients","volume":"28","author":"Lee","year":"2020","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.survophthal.2024.12.004_bib53","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ajoc.2016.12.025","article-title":"Choroidal neovascularization secondary to tuberculosis: presentation and management","volume":"5","author":"Lee Kim","year":"2017","journal-title":"Am J Ophthalmol Case Rep"},{"issue":"5","key":"10.1016\/j.survophthal.2024.12.004_bib54","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.ajo.2009.06.010","article-title":"Bevacizumab in inflammatory eye disease","volume":"148","author":"Lott","year":"2009","journal-title":"Am J Ophthalmol"},{"issue":"11","key":"10.1016\/j.survophthal.2024.12.004_bib55","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1038\/eye.2010.131","article-title":"Intravitreal ranibizumab in the treatment of choroidal neovascularisation secondary to ocular toxocariasis in a 13-year-old boy","volume":"24","author":"Lyall","year":"2010","journal-title":"Eye"},{"issue":"3","key":"10.1016\/j.survophthal.2024.12.004_bib56","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jcjo.2012.03.042","article-title":"Three-year visual and anatomic results of administrating intravitreal bevacizumab in inflammatory ocular neovascularization","volume":"47","author":"Mansour","year":"2012","journal-title":"Can J Ophthalmol"},{"issue":"3","key":"10.1016\/j.survophthal.2024.12.004_bib57","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.ajo.2008.05.024","article-title":"Intravitreal bevacizumab in inflammatory ocular neovascularization","volume":"146","author":"Mansour","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2024.12.004_bib58","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.2147\/OPTH.S34294","article-title":"Five-year visual results of intravitreal bevacizumab in refractory inflammatory ocular neovascularization","volume":"6","author":"Mansour","year":"2012","journal-title":"Clin Ophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2024.12.004_bib59","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/eye.2012.262","article-title":"Intravitreal methotrexate for the treatment of choroidal neovascularization in multifocal choroiditis","volume":"27","author":"Mateo-Montoya","year":"2013","journal-title":"Eye"},{"issue":"2","key":"10.1016\/j.survophthal.2024.12.004_bib60","doi-asserted-by":"crossref","DOI":"10.1111\/j.1755-3768.2009.01541.x","article-title":"Intravitreal ranibizumab for choroidal neovascularization secondary to acute multifocal posterior placoid pigment epitheliopathy","volume":"88","author":"Mavrakanas","year":"2010","journal-title":"Acta Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2024.12.004_bib61","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1869-5760-3-13","article-title":"Peripapillary choroidal neovascularization in pars planitis","volume":"3","author":"Mehta","year":"2013","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"10.1016\/j.survophthal.2024.12.004_bib62","doi-asserted-by":"crossref","DOI":"10.1080\/09273948.2024.2348117","article-title":"Unraveling the spectrum of uveitis: Insights from an epidemiological study in a national referral center in northern Italy","author":"Menean","year":"2024","journal-title":"Ocul Immunol Inflamm"},{"issue":"9","key":"10.1016\/j.survophthal.2024.12.004_bib63","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1097\/IAE.0b013e3181d374dc","article-title":"Positive response to intravitreal ranibizumab in the treatment of choroidal neovascularization secondary to punctate inner choroidopathy","volume":"30","author":"Menezo","year":"2010","journal-title":"Retina"},{"issue":"4","key":"10.1016\/j.survophthal.2024.12.004_bib64","doi-asserted-by":"crossref","first-page":"245","DOI":"10.4103\/0974-9233.58422","article-title":"Inflammatory choroidal neovascularization","volume":"16","author":"Neri","year":"2009","journal-title":"Middle East Afr J Ophthalmol"},{"issue":"5","key":"10.1016\/j.survophthal.2024.12.004_bib65","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s10792-009-9323-x","article-title":"Association of systemic steroids and mycophenolate mofetil as rescue therapy for uveitic choroidal neovascularization unresponsive to the traditional immunosuppressants: interventional case series","volume":"30","author":"Neri","year":"2010","journal-title":"Int Ophthalmol"},{"issue":"6","key":"10.1016\/j.survophthal.2024.12.004_bib66","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1080\/09273948.2020.1727530","article-title":"Systemic immunosuppression is highly effective in the long-term control of inflammatory non-infectious uveitic choroidal neovascularization: a comparative study","volume":"29","author":"Neri","year":"2021","journal-title":"Ocul Immunol Inflamm"},{"issue":"2","key":"10.1016\/j.survophthal.2024.12.004_bib67","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.ophtha.2017.09.002","article-title":"Risk factors for developing choroidal neovascular membrane and visual loss in punctate inner choroidopathy","volume":"125","author":"Niederer","year":"2018","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.survophthal.2024.12.004_bib68","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1136\/bjophthalmol-2013-304237","article-title":"Intravitreal bevacizumab for choroidal neovascularisation in serpiginous choroiditis","volume":"98","author":"Parodi","year":"2014","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"10.1016\/j.survophthal.2024.12.004_bib69","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.ophtha.2015.10.056","article-title":"Risk of retinal neovascularization in cases of uveitis","volume":"123","author":"Patel","year":"2016","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.survophthal.2024.12.004_bib70","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1097\/IAE.0000000000002864","article-title":"Choroidal granulomas visualized by swept-source optical coherence tomography angiography","volume":"41","author":"Pichi","year":"2021","journal-title":"Retina"},{"issue":"1","key":"10.1016\/j.survophthal.2024.12.004_bib71","doi-asserted-by":"crossref","DOI":"10.1186\/s12348-024-00402-4","article-title":"Fluocinolone acetonide 0.2 \u00b5g\/day intravitreal implant in non-infectious uveitis affecting the posterior segment: EU expert user panel consensus-based clinical recommendations","volume":"14","author":"Pleyer","year":"2024","journal-title":"J Ophthalmic Inflamm Infect"},{"issue":"8","key":"10.1016\/j.survophthal.2024.12.004_bib72","first-page":"1377","article-title":"The chrysanthemum phenotype of idiopathic multifocal choroiditis","volume":"43","author":"Ramtohul","year":"2023","journal-title":"Retina"},{"issue":"11","key":"10.1016\/j.survophthal.2024.12.004_bib73","first-page":"1960","article-title":"Punctate inner pachychoroidopathy","volume":"43","author":"Ramtohul","year":"2023","journal-title":"Retina"},{"issue":"11","key":"10.1016\/j.survophthal.2024.12.004_bib74","first-page":"1890","article-title":"Multizonal outer retinopathy and retinal pigment epitheliopathy (MORR)","volume":"43","author":"Ramtohul","year":"2023","journal-title":"Retina"},{"key":"10.1016\/j.survophthal.2024.12.004_bib75","first-page":"1","article-title":"Multimodal imaging of vitreo-retinal lymphoma: a comprehensive review","author":"Rissotto","year":"2024","journal-title":"Ocul Immunol Inflamm"},{"issue":"3","key":"10.1016\/j.survophthal.2024.12.004_bib76","doi-asserted-by":"crossref","first-page":"B2","DOI":"10.4103\/pajo.pajo_24_24","article-title":"Choroidal neovascularization in unilateral acute idiopathic maculopathy associated with coxsackievirus","volume":"6","author":"Roizenblatt","year":"2024","journal-title":"Pan-Am J Ophthalmol"},{"issue":"5","key":"10.1016\/j.survophthal.2024.12.004_bib77","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1097\/IAE.0b013e3182003ca8","article-title":"Intravitreal ranibizumab for the treatment of inflammatory choroidal neovascularization","volume":"31","author":"Rouvas","year":"2019","journal-title":"Retina"},{"issue":"4","key":"10.1016\/j.survophthal.2024.12.004_bib78","doi-asserted-by":"crossref","first-page":"295","DOI":"10.4103\/ijo.IJO_262_16","article-title":"Inflammatory choroidal neovascularization in Indian eyes: Etiology, clinical features, and outcomes to anti-vascular endothelial growth factor","volume":"65","author":"Roy","year":"2017","journal-title":"Indian J Ophthalmol"},{"issue":"5","key":"10.1016\/j.survophthal.2024.12.004_bib79","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.ajo.2007.12.030","article-title":"Intravitreal bevacizumab for choroidal neovascularization in ocular histoplasmosis","volume":"145","author":"Schadlu","year":"2008","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.survophthal.2024.12.004_bib80","doi-asserted-by":"crossref","first-page":"318","DOI":"10.4103\/0301-4738.82005","article-title":"Intravitreal ranibizumab for the treatment of choroidal neovascularization secondary to ocular toxoplasmosis","volume":"59","author":"Shah","year":"2011","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.survophthal.2024.12.004_bib81","article-title":"Results of intravitreal anti-vascular endothelial growth factor therapy in inflammatory choroidal neovascularization","author":"Sourour Zina","year":"2021","journal-title":"J Curr Ophthalmol"},{"key":"10.1016\/j.survophthal.2024.12.004_bib82","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.preteyeres.2017.11.003","article-title":"Optical coherence tomography angiography","volume":"64","author":"Spaide","year":"2018","journal-title":"Prog Retin Eye Res"},{"issue":"5","key":"10.1016\/j.survophthal.2024.12.004_bib83","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.ajo.2011.04.011","article-title":"Diagnostic evaluation of type 2 (classic) choroidal neovascularization: Optical coherence tomography, indocyanine green angiography, and fluorescein angiography","volume":"152","author":"Sulzbacher","year":"2011","journal-title":"Am J Ophthalmol"},{"issue":"12","key":"10.1016\/j.survophthal.2024.12.004_bib84","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1016\/j.ophtha.2006.05.067","article-title":"Multifocal choroiditis with panuveitis","volume":"113","author":"Thorne","year":"2006","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.survophthal.2024.12.004_bib85","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1167\/iovs.17-22902","article-title":"Comparison of SD-optical coherence tomography angiography and indocyanine green angiography in type 1 and 2 neovascular age-related macular degeneration","volume":"59","author":"Told","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"12","key":"10.1016\/j.survophthal.2024.12.004_bib86","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1007\/s00417-008-0906-4","article-title":"Intravitreal bevacizumab for refractory choroidal neovascularization (CNV) secondary to uveitis","volume":"246","author":"Tran","year":"2008","journal-title":"Graefe'S Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.survophthal.2024.12.004_bib87","first-page":"1","article-title":"Corticosteroids decrease the incidence and activity of choroidal neovascularization in patients with punctate inner choroidopathy or multifocal choroiditis","author":"Vienne-Jumeau","year":"2023","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.survophthal.2024.12.004_bib88","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.ajo.2021.07.010","article-title":"Intravitreal antivascular endothelial growth factor treatment for inflammatory choroidal neovascularization in noninfectious uveitis","volume":"236","author":"Woronkowicz","year":"2022","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2024.12.004_bib89","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s10384-008-0600-4","article-title":"Intravitreal bevacizumab for choroidal neovascularization secondary to Vogt-Koyanagi-Harada syndrome","volume":"53","author":"Wu","year":"2009","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.survophthal.2024.12.004_bib90","first-page":"1","article-title":"Treatment of punctate inner choroidopathy with choroidal neovascularization using corticosteroid and intravitreal ranibizumab","author":"Wu","year":"2018","journal-title":"BioMed Res Int"},{"issue":"ement 1","key":"10.1016\/j.survophthal.2024.12.004_bib91","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1097\/IAE.0b013e31823f9afa","article-title":"Unilateral acute idiopathic maculopathy","volume":"32","author":"Yannuzzi","year":"2012","journal-title":"Retina"},{"issue":"6","key":"10.1016\/j.survophthal.2024.12.004_bib92","doi-asserted-by":"crossref","first-page":"699","DOI":"10.3109\/09273948.2015.1109669","article-title":"Optical coherence tomography angiography of choroidal neovascularization associated with tuberculous serpiginous-like choroiditis","volume":"24","author":"Yee","year":"2016","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.survophthal.2024.12.004_bib93","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/09273948.2016.1239744","article-title":"Intravitreal administration of ranibizumab and bevacizumab for choroidal neovascularization secondary to ocular toxocariasis: a case report","author":"Yoon","year":"2016","journal-title":"Ocul Immunol Inflamm"},{"issue":"5","key":"10.1016\/j.survophthal.2024.12.004_bib94","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1097\/IAE.0000000000002984","article-title":"Optical coherence tomography features of choroidal neovascularization and their correlation with age, gender, and underlying disease","volume":"41","author":"Zicarelli","year":"2021","journal-title":"Retina"}],"container-title":["Survey of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625724001553?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625724001553?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T09:46:23Z","timestamp":1741081583000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039625724001553"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":94,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S0039625724001553"],"URL":"https:\/\/doi.org\/10.1016\/j.survophthal.2024.12.004","relation":{},"ISSN":["0039-6257"],"issn-type":[{"value":"0039-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inflammatory choroidal neovascularization: An evidence-based update","name":"articletitle","label":"Article Title"},{"value":"Survey of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.survophthal.2024.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}